학술논문

A phase II trial of nivolumab and denosumab association as second-line treatment for stage IV non-small-cell lung cancer (NSCLC) with bone metastases: DENIVOS study (GFPC 06-2017)
Document Type
Journal
Source
ANNALS OF ONCOLOGY; SEP 2022, 33 7, pS1028-pS1029, 2p. Supplement: 7
Subject
Language
English
ISSN
15698041